newsfilter
← Latest News
GlobeNewswire·

TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance